CLINICAL_TRIALS
trial_result
· 2023-12-11
Clinical Trial Update: A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1) [Phase 2]
Summary
Phase 2 trial investigating camostat for COVID-19 infection; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cancer Research UK | Conditions: COVID-19 Infection | Phase 2 | Status: TERMINATED | Results posted: 2023-12-11